|
DNAJC14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.31469995685075E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.49920000437032E-08 |
| Normal-vs-Stage2 |
1.627670E-02 |
| Normal-vs-Stage3 |
3.63870045205772E-11 |
| Normal-vs-Stage4 |
2.51900000858285E-09 |
| Stage1-vs-Stage2 |
5.930300E-02 |
| Stage1-vs-Stage3 |
1.472420E-02 |
| Stage1-vs-Stage4 |
1.658130E-02 |
| Stage2-vs-Stage3 |
1.958580E-03 |
| Stage2-vs-Stage4 |
1.821780E-03 |
| Stage3-vs-Stage4 |
8.532000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.00570002220724E-09 |
| Normal-vs-AfricanAmerican |
1.364070E-03 |
| Normal-vs-Asian |
3.1696000000192E-06 |
| Caucasian-vs-AfricanAmerican |
5.765000E-01 |
| Caucasian-vs-Asian |
7.493000E-01 |
| AfricanAmerican-vs-Asian |
6.937000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.39219996326312E-09 |
| Normal-vs-Female |
6.71930000528675E-09 |
| Male-vs-Female |
3.685000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.36669999445994E-08 |
| Normal-vs-Age(41-60Yrs) |
3.13769999982227E-07 |
| Normal-vs-Age(61-80Yrs) |
9.17410000189633E-08 |
| Normal-vs-Age(81-100Yrs) |
5.919300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.638400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.143800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.828800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.437200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.643600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.872600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.355500E-04 |
| Classical-VS-Follicular |
7.248600E-01 |
| Classical-VS-Other |
3.253600E-01 |
| Classical-VS-Normal |
1.07800000004321E-06 |
| Tall-VS-Follicular |
5.642600E-03 |
| Tall-VS-Other |
6.661400E-01 |
| Tall-VS-Normal |
7.08630043533276E-10 |
| Follicular-VS-Other |
4.252200E-01 |
| Follicular-VS-Normal |
3.408800E-04 |
| Other-VS-Normal |
6.800200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.72709999968212E-07 |
| Normal-vs-N1 |
2.95219959589588E-10 |
| N0-vs-N1 |
7.041600E-03 |
|
|
